Image

Breaking up Sedentary Time in Rheumatoid Arthritis

Breaking up Sedentary Time in Rheumatoid Arthritis

Recruiting
18-60 years
Female
Phase N/A

Powered by AI

Overview

This study will verify the effects of breaking up sitting time with short bouts of light intensity walking on vascular function in women with rheumatoid arthritis.

Description

Women diagnosed with rheumatoid arthritis will participate in this randomized crossover trial. In one of the experimental sessions, the participants will remain 4-h on uninterrupted sitting, and in another day they will perform 3-min light intensity walk every 30 min to break up the sitting position. Vascular function will be assessed before and after each intervention using the following devices/techniques: a) transcranial Doppler ultrasound to assess the middle cerebral artery blood flow velocity at baseline and in response to CO2 breathing (5% CO2 mixture for 3 min), and to repeated sit-to-stand transitions; b) a multi-frequency linear transducer (7-12 MHz) attached to a high-resolution ultrasound machine to assess femoral artery dilation after reactive hyperemia (i.e., flow-mediated dilation); c) a laser Doppler probe attached to the skin surface of the right shin in order to quantify the Laser Doppler flux at baseline and during reactive hyperemia. Additionally, healthy age- and body mass-matched women will be recruited and will only perform the pre-intervention tests.

Eligibility

Inclusion Criteria:

  • Adult women diagnosed with RA
  • From the Rheumatology Clinic at the Liverpool University Hospitals NHS Foundation Trust
  • Aged 18-60 yr
  • Non-smoker for at least 6months
  • Able to provide written informed consent.

Exclusion Criteria:

  • Cannot readily read and understand English.
  • Currently smoking or within last 6 months.
  • Alcohol consumption >14units per week.
  • Symptoms of or established cardiovascular disease (except hypertension)
  • Previous stroke or myocardial infarction.
  • History of diabetes or respiratory disease or chronic kidney disease.
  • Musculoskeletal impairment/disability precluding physical activity
  • Unstable medication (change in medication within the 3 months)
  • Aged <18 or > 60 yr
  • Currently pregnant

Study details
    Rheumatoid Arthritis
    Sedentary Behavior
    Endothelial Dysfunction

NCT05284110

Liverpool John Moores University

28 January 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.